A recent study found that impotence pill manufacturers regularly violated principles laid out by PhRMA to protect children from seeing ads for the drugs. During the study period, the public was exposed to 500 billion TV ad impressions for impotence therapies, and more than 100 billion of those were seen by those younger than 18. Drugmakers commenting on the study emphasized their commitment to responsible marketing, and PhRMA noted the many benefits of DTC advertising "including raising awareness of diseases and treatment options and empowering patients."

Full Story:

Related Summaries